Vessel inflammation and morphological changes in patients with large vessel vasculitis: a retrospective study.


Journal

RMD open
ISSN: 2056-5933
Titre abrégé: RMD Open
Pays: England
ID NLM: 101662038

Informations de publication

Date de publication:
01 2022
Historique:
received: 25 09 2021
accepted: 01 12 2021
entrez: 6 1 2022
pubmed: 7 1 2022
medline: 7 4 2022
Statut: ppublish

Résumé

The aim was to identify any association between imaging signs of vessel wall inflammation (positron emission tomography-CT (PET-CT) score and CT/MR wall thickening) and synchronous and subsequent vascular damage (stenoses/dilations) in patients with large vessel vasculitis (LVV). Consecutive patients with LVV referred to a tertiary centre in 2007-2020 with baseline PET-CT and morphological imaging (CT/MR angiography) performed within 3 months were included. All available PET-CT and CT/MR scans were reviewed to assess PET-CT uptake (4-point semi-quantitative score), wall thickening, stenoses and dilations for 15 vascular segments. The associations of baseline PET score and CT/MR wall thickening with synchronous and incident stenoses/dilations at CT/MR performed 6-30 months from baseline were evaluated in per-segment and per-patient analyses. Respective areas under the receiver operating characteristic curve (AUC) were calculated. We included 100 patients with LVV (median age: 48 years, 22% males). Baseline PET score and wall thickening were strongly associated (Cuzick non-parametric test for trend across order groups (NPtrend) <0.001). The association with synchronous stenoses/dilations was weak for PET score (NPtrend=0.01) and strong for wall thickening (p<0.001). In per-patient analyses, sensitivity/specificity for ≥1 synchronous stenoses/dilations were 44%/67% for PET score ≥2 and 66.7%/60.5% for wall thickening. Subsequent CTs/MRs were available in 28 patients, with seven incident stenoses/dilations. Baseline PET score was strongly associated with incident stenoses/dilations (p=0.001), while baseline wall thickening was not (p=0.708), with AUCs for incident stenoses/dilations of 0.80 for PET score and 0.52 for wall thickening. PET score and wall thickening are strongly associated, but only baseline PET score is a good predictor of incident vessel wall damage in LVV.

Identifiants

pubmed: 34987095
pii: rmdopen-2021-001977
doi: 10.1136/rmdopen-2021-001977
pmc: PMC8734042
pii:
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Rheumatology (Oxford). 2018 Feb 1;57(suppl_2):ii32-ii42
pubmed: 29982778
Ann Intern Med. 1994 Jun 1;120(11):919-29
pubmed: 7909656
Arthritis Rheum. 2002 Jun;46(6):1634-42
pubmed: 12115196
Int J Cardiol. 2012 Mar 8;155(2):262-7
pubmed: 21059475
Arthritis Rheum. 2008 Aug;58(8):2574-8
pubmed: 18668559
Sci Rep. 2019 Aug 27;9(1):12388
pubmed: 31455785
Ann Rheum Dis. 2018 Aug;77(8):1165-1171
pubmed: 29666047
Radiology. 2014 Jan;270(1):74-81
pubmed: 24009351
Clin Exp Rheumatol. 2021 Mar-Apr;39 Suppl 129(2):69-75
pubmed: 33253103
Medicine (Baltimore). 2015 Feb;94(5):e486
pubmed: 25654393
Arthritis Rheum. 1990 Aug;33(8):1129-34
pubmed: 1975175
Arthritis Rheumatol. 2018 Mar;70(3):439-449
pubmed: 29145713
Rheumatology (Oxford). 2008 Aug;47(8):1179-84
pubmed: 18515868
Rheumatol Int. 2020 Jul;40(7):1123-1131
pubmed: 32200427
Int J Rheum Dis. 2019 Jan;22 Suppl 1:41-48
pubmed: 29624864
JACC Cardiovasc Imaging. 2014 Jun;7(6):605-19
pubmed: 24925329
JACC Cardiovasc Imaging. 2018 Dec;11(12):1879-1882
pubmed: 30121275
Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):99-106
pubmed: 29799393
Arthritis Rheum. 2007 Mar;56(3):1000-9
pubmed: 17328078
Int J Rheum Dis. 2015 Sep;18(7):714-24
pubmed: 26177990
Medicine (Baltimore). 2016 Jun;95(26):e3851
pubmed: 27367985
Ann Rheum Dis. 2014 Oct;73(10):1826-32
pubmed: 23873881
Autoimmun Rev. 2019 Dec;18(12):102405
pubmed: 31648043
Eur J Nucl Med Mol Imaging. 2003 May;30(5):730-6
pubmed: 12677302
Semin Arthritis Rheum. 2021 Aug;51(4):786-792
pubmed: 34148007
Curr Rheumatol Rep. 2020 Aug 26;22(10):68
pubmed: 32845392
Autoimmun Rev. 2011 Dec;11(2):132-6
pubmed: 21946651
Rheumatology (Oxford). 2021 Aug 2;60(8):3851-3861
pubmed: 33831144
Semin Arthritis Rheum. 2019 Jun;48(6):1074-1082
pubmed: 30424972
Ann Rheum Dis. 2018 May;77(5):636-643
pubmed: 29358285

Auteurs

Giulia Besutti (G)

Department of Radiology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Francesco Muratore (F)

Unit of Rheumatology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Pamela Mancuso (P)

Department of Epidemiology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Marco Ferrari (M)

Department of Radiology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy marco.ferrari@ausl.re.it.

Elena Galli (E)

Unit of Rheumatology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Unit of Rheumatology, University of Modena and Reggio Emilia, Modena, Italy.

Lucia Spaggiari (L)

Department of Radiology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Filippo Monelli (F)

Department of Radiology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Clinical and Experimental Medicine PhD program, University of Modena and Reggio Emilia, Modena, Italy.

Massimiliano Casali (M)

Nuclear Medicine Unit, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Emilia-Romagna, Italy.

Annibale Versari (A)

Nuclear Medicine Unit, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Emilia-Romagna, Italy.

Luigi Boiardi (L)

Unit of Rheumatology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Chiara Marvisi (C)

Unit of Rheumatology, University of Modena and Reggio Emilia, Modena, Italy.

Guido Ligabue (G)

Department of Radiology, University of Modena and Reggio Emilia, Modena, Italy.

Pierpaolo Pattacini (P)

Department of Radiology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Paolo Giorgi Rossi (P)

Department of Epidemiology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Carlo Salvarani (C)

Unit of Rheumatology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Department of Surgery, Medicine, Dentistry and Morphological Sciences with interest in Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH